SAMAALB

Welcome to the Brand page for “SAMAALB”, which is offered here for Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of bacteria-based diseases and disorders, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; antifungal, anti-infective, antiviral and antibiotic preparations;.

Its status is currently believed to be active. Its class is unavailable. “SAMAALB” is believed to be currently owned by “NOVARTIS AG”.